Budget Impact Analysis of Gene Therapies for Recessive Dystrophic Epidermolysis Bullosa

By afschroeder • September 10, 2026

Raymakers AJN, Kesselheim AS, Feldman WB. Budget Impact Analysis of Gene Therapies for Recessive Dystrophic Epidermolysis Bullosa. JAMA Dermatol. 2026 Sep 9:e263240. doi: 10.1001/jamadermatol.2026.3240. Epub ahead of print. PMID: 42714920; PMCID: PMC13559720.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Moderators of the Effects of Telehealth Mindfulness-based Interventions for Chronic Pain: A Secondary Responder Analysis of the LAMP Randomized Controlled Trial

Calvert CM, Hagel Campbell EM, Cross LJS, Bangerter A, Bronfort G, Evans R, Meis LA, Haley A, Leininger B, Matthias M, Polusny M, Allen K,[...]

Leveraging scholarship to lead

Moriates C. Leveraging scholarship to lead. J Hosp Med. 2026 Sep 9. doi: 10.1002/jhm.70478. Epub ahead of print. PMID: 42717657.

Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension

Alotaibi M, Tang A, Sun N, Gurholt I, Yuguchi E, Roberts K, Preston I, Warburton R, Yuan JX, Kim NH, Chan SY, Jain M, Cheng[...]